Genetic Analysis Finds New Leukemia Therapy
The computational power available to researchers has grown exponentially over the years, allowing broad analysis of genetics involved in cancer to get new ideas for exploring new methods of therapy.
Are Hispanics at Greater Risk of Leukemia?
Several groups looking at data from broad genetic studies have noticed differences in cancer risk for different populations according to ethnic make up.
Insights into Early Childhood Leukemia
A project to sequence genetic mutations in a particularly aggressive form of childhood leukemia developed a list of common mutations - the first step in developing adequate pharmaceutical targeted therapy.
Targeted Therapy Hits the Mark
People with chronic myeloid leukemia ( CML ) have been treated with interferon therapy for years, but this treatment can sometimes fail. And when it does, a targeted therapy hits the mark, offering these patients long-term benefits.
Blocking the Blockers
Drugs known as tyrosine kinase inhibitors are currently state-of-the-art treatment for chronic myeloid leukemia ( CML ). These medicines don't cure the disease, in part because leukemia has a powerful defense system. Recent research suggests there's a way around these defensive linemen.
Down Syndrome Ups Leukemia Risks
Another heartbreaking fact about Down syndrome is that children with this condition are increased risk of developing leukemia. And researchers are now beginning to understand why.
FDA Saves "Dangerous Drug Shortage"
Methotrexate is the one drug children with leukemia must have in order to beat the potentially deadly disease. But it was on the brink of becoming unavailable, until the U.S. Food & Drug Administration (FDA) stepped in to - literally - save lives.
Heart Disease After Childhood Leukemia - Why?
Treating childhood cancers usually requires medications, some of which can be toxic to the heart. So will these drugs cause heart problems later on in life? Recent research asked just that question.
Outwitting Chronic Myeloid Leukemia
About 20 percent of all leukemias in the Western world are chronic myeloid leukemia ( CML ). Today's treatments target an abnormal chromosome that causes the disease, but new theories about how to outwit this resilient disease are sprouting.
Tasigna Recommended for Second-Line CML
Tasigna ( nilotinib ) is one of the three major medications currently being used to treat chronic myeloid leukemia ( CML ). Now it has become a preferred drug in one country.